News GSK’s Relvar Ellipta comes out on top in real world study Encouraging results will support growth of its next generation respiratory treatment
News GSK and J&J lead in vaccines research – but pricing still an... GlaxoSmithKline and Johnson & Johnson are leading R&D investment in vaccines, and the field is producing the first ever vaccines for conditions such as Ebola and a range of deadly b
News Good news for GSK’s next generation asthma drug Results mean patients could switch to once-daily inhaler use
Gilead Gilead aims to challenge GSK's HIV drug Tivicay But GSK hit back with plans for two-drug regimen.
Views & Analysis Exclusive: Brexit likely to cause long-term damage to UK pha... Exclusive survey finds concerns about future of UK pharma industry
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
